5-(dichloromethyl)-7-(4-methylphenyl)-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine
C13H8Cl2F3N5 — CID 51064862
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(dichloromethyl)-7-(4-methylphenyl)-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine
5-(dichloromethyl)-7-(4-methylphenyl)-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine (PubChem CID 51064862) has the molecular formula C13H8Cl2F3N5 and a molecular weight of 362.14 g/mol. Its IUPAC name is 5-(dichloromethyl)-7-(4-methylphenyl)-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine.
Molecular Properties
| Compound Name | 5-(dichloromethyl)-7-(4-methylphenyl)-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine |
|---|---|
| PubChem CID | 51064862 |
| Molecular Formula | C13H8Cl2F3N5 |
| Molecular Weight | 362.14 g/mol |
| Exact Mass | 361.01 |
| IUPAC Name | 5-(dichloromethyl)-7-(4-methylphenyl)-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine |
| SMILES | Cc1ccc(-c2nc(C(Cl)Cl)nc3nc(C(F)(F)F)nn23)cc1 |
| InChI | InChI=1S/C13H8Cl2F3N5/c1-6-2-4-7(5-3-6)10-19-9(8(14)15)20-12-21-11(13(16,17)18)22-23(10)12/h2-5,8H,1H3 |
| InChIKey | DCPYTJBLZIHYDV-UHFFFAOYSA-N |
| XLogP | 3.99 |
| TPSA | 55.97 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 362.14 |
| LogP ≤ 5 | 3.99 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 51064862 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.